Suchergebnisse - "Naccarato, Mark"

PubPharm (28)

1

Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures

enthalten in: International journal of STD & AIDS | 2024

von Clifford Rashotte, M. | Yoong, D. | Naccarato, M. | +4

2

Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine : A case series

enthalten in: HIV medicine | 2023

von DeKoven, S. | Naccarato, M. | Brumme, C. | +1

3

A pharmacist-led interprofessional learning experience for family practice medical residents specializing in HIV care

enthalten in: Canadian medical education journal | 2023

von Naccarato, M. | Yoong, D. | Gough, K. | +2

4

Treatment‐emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine : A case series

enthalten in: HIV Medicine | 2023

von DeKoven, S. | Naccarato, M. | Brumme, C. | +1

5

Feasibility of implementing a same-day electronic screening tool for clinical assessment to measure patient-reported outcomes for eliciting actionable information on adherence to HIV medication and related factors in a busy Canadian urban HIV clinic

enthalten in: International journal of STD & AIDS | 2022

von Suri, S. | Yoong, D. | Short, D. | +7

6

Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient : is it time for a priori tacrolimus dosage reduction?

enthalten in: AIDS (London, England) | 2021

von Naccarato, M. | Kwee, F. | Zaltzman, J. | +1

7

The PrEP You Want : A Web-Based Survey of Online Cross-Border Shopping for HIV Prophylaxis Medications

enthalten in: Journal of medical Internet research | 2019

von Walmsley, B. | Gallant, D. | Naccarato, M. | +3

8

High prevalence of syndemic health problems in patients seeking post-exposure prophylaxis for sexual exposures to HIV

enthalten in: PloS one | 2018

von Morrison, S. | Yoong, D. | Hart, T. | +6

9

Combination Therapy with Tenofovir Disoproxil Fumarate/Emtricitabine/Elvitegravir/Cobicistat Plus Darunavir Once Daily in Antiretroviral-Naive and Treatment-Experienced Patients : A Retrospective Review

enthalten in: Journal of the International Association of Providers of AIDS Care | 2018

von Naccarato, M. | Yoong, D. | Fong, I. | +3

10

Reply : Extensive Bruising and Elevated Rivaroxaban Plasma Concentration in a Patient Receiving Cobicistat-Boosted Elvitegravir

enthalten in: The Annals of pharmacotherapy | 2017

von Yoong, D. | Naccarato, M. | Gough, K.

CommentOn: Ann Pharmacother. 2017 Aug;51(8):713-714. - PMID 28351160